No Data
No Data
Craig-Hallum Maintains Exact Sciences(EXAS.US) With Buy Rating
Exact Sciences Appoints Leslie Trigg to Board
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Phathom Pharmaceuticals (PHAT) and Exact Sciences (EXAS)
Exact Sciences to Present Cologuard Test Adherence and Predicted Preference Data at Digestive Disease Week 2025
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
Exact Sciences, CAVA, Lockheed, Intuit, Coinbase: Trending by Analysts